BioScience Health Innovations, Inc.
Information BioScience Health Innovations Inc. ( we, us, the Company ) was incorporated in the State of Nevada on July 8, 2019 with the name Nowtransit, Inc. and we changed our name to BioScience Health Innovations Inc. on February 21, 2025. Investors should carefully consider the following Risk Factors before deciding whether to invest in the Company.
$6.00
-$0.78 (-11.50%)
EOD Oct 21, 2026
12.64% operating margin is respectable but not wide. ROIC at 55.53%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue up 208.3% YoY with margins expanding 7.9pp.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$4M
▲ +208.3% YoY
Net Income (TTM)
-$658K
▲ +638.0% YoY
Op. Margin
-13.65%
▲ +7.9pp YoY
ROIC
-26.09%
▲ +39.1pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$2M
▲ +642.5% YoY
Net Debt
-$452K
Net Cash Position
Cash & Equiv.
$712K
Continue Research
SourceComputed from the 10-Q filed 6 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 18 Sept 2026. How this is calculated.
Price from market data, last close as of 21 Oct 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.
Is BioScience Health Innovations (BHIC) overvalued?
BioScience Health Innovations (BHIC)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, BioScience Health Innovations scores 40/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
Is BioScience Health Innovations a high-quality business?+
BioScience Health Innovations scores 40 out of 100 on Intrinsiqq's quality score, a weighted blend of 5 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a -13.7% operating margin and a -26.1% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Is BioScience Health Innovations a good stock to buy right now?+
That depends on valuation and quality together, not either alone. you should weigh BHIC's valuation and scores 40/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.
Related stocks: Services-Computer Processing & Data Preparation
Spot a number that looks wrong? Check it in BHIC's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing BHIC
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.